https://cancerblog.mayoclinic.org/2022/03/03/mayo-clinic-cancer-center-researchers-identify-promising-drug-to-treat-gastrointestinal-cancers/
Mayo Clinic Cancer Center researchers identify promising drug to treat gastrointestinal cancers -...
Mar 17, 2022 - Research on adagrasib has demonstrated promising clinical activity in patients with gastrointestinal cancers that harbor KRAS G12C mutations.
mayo clinic cancer center